<DOC>
	<DOCNO>NCT01496417</DOCNO>
	<brief_summary>This pilot study investigate use belatacept ( BMS ) therapy kidney transplant patient MAPI score great equal 8 . The MAPI ( Maryland Aggregate Pathology Index ) score preimplantation donor score system five histopathological parameter impact long-term kidney outcome . Many kidney transplant recipient use calcineurin inhibitor ( CNIs ) one anti-rejection medi cation . Kidney function may affect anti-rejection medication know calcineurin inhibitor ( CNIs ) . Sometimes CNIs lead toxicity eventually loss kidney episodes chronic allograft nephropathy ( CAN ) . Avoiding CNI immunosuppression use belatacept therapy ( BMS ) instead , may associate improved kidney transplant outcome .</brief_summary>
	<brief_title>Belatacept Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index ( MAPI ) Scores</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Male female renal recipient 1870 year age undergoing primary kidney transplantation . Recipients decease donor ( include expand criterion donor organ decease donor organ cardiac death ) MAPI score â‰¥ 8 . Cold ischemic time le 40 hour time reperfusion . Negative serum pregnancy test female patient . Patients understand purpose risk study , provide informed consent , comply treatment followup requirement . Cold ischemic time ( CIT ) &gt; 40 hour Patients sensitize current PRA &gt; 40 % , ABO incompatible transplant , T , B cell crossmatch positive transplant . Patients without antibody EBV Patients receive multiple organ transplant . Patients unable take oral medication time randomization Patient history malignancy organ system , treat untreated , within past 2 year whether evidence local recurrence metastasis , exception carcinoma situ Patients test positive HIV , Hepatitis C Hepatitis B surface antigen . Recipients organs donor test positive HIV , Hepatitis C Hepatitis B surface antigen Patients clinically significant systemic infection within 30 day prior transplant Patients cardiac failure time screen severe cardiac disease determine investigator Patients abnormal laboratory finding clinical significance within 2 week randomization would interfere objective study . Females , pregnant lactating , childbearing potential unwilling use effective mean contraception plan become pregnant . Patient active tuberculosis infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Biopsy</keyword>
	<keyword>Belatacept</keyword>
</DOC>